Company Overview

Ansell Limited is a global provider of personal protective equipment (PPE) specializing in hand and body protection solutions for industrial, healthcare, and life sciences applications. The company operates primarily within the healthcare supplies, industrial safety, and protective equipment industries, serving customers that require high-performance safety products in regulated and hazardous environments. Its core offerings include medical examination and surgical gloves, industrial work gloves, chemical-resistant garments, and specialized protective solutions.

The company’s primary revenue drivers are disposable and durable gloves used in healthcare and industrial settings, with key customer segments including hospitals, laboratories, manufacturers, utilities, and emergency services. Ansell is positioned as a premium, innovation-led PPE provider with a strong focus on proprietary materials, ergonomic design, and regulatory compliance. Founded in Australia in the late 19th century as part of the Dunlop organization, Ansell evolved from a rubber manufacturing business into a global PPE specialist and became an independent, publicly listed company in the early 2000s following its demerger from Dunlop Australia.

Business Operations

Ansell operates through three main business segments: Healthcare Global Business Unit, Industrial Global Business Unit, and Life Sciences Global Business Unit. The Healthcare Global Business Unit focuses on medical examination and surgical gloves used by hospitals and healthcare professionals, while the Industrial Global Business Unit supplies mechanical, chemical, and cut-resistant gloves for manufacturing, energy, and infrastructure customers. The Life Sciences Global Business Unit serves pharmaceutical, biotechnology, and cleanroom environments with contamination-controlled protective products.

The company generates revenue through the manufacture and distribution of PPE products across both developed and emerging markets, supported by owned manufacturing facilities and third-party production partners. Ansell controls proprietary technologies related to glove formulation, barrier protection, and ergonomic design. Its operating structure includes wholly owned subsidiaries such as Ansell Healthcare LLC and Ansell Industrial Inc., along with long-term supplier and manufacturing relationships in Asia to support global scale and cost efficiency.

Strategic Position & Investments

Ansell’s strategic direction emphasizes premiumization, innovation, and portfolio optimization, with a focus on higher-margin products and long-term customer contracts. Growth initiatives include expanding penetration in healthcare and life sciences markets, increasing automation in manufacturing, and investing in sustainable materials and processes. The company has also pursued targeted acquisitions to strengthen its industrial and specialty PPE offerings.

Notable acquisitions include KBU Protection, which expanded Ansell’s capabilities in chemical protective clothing, and Ringers Gloves, which strengthened its position in oil and gas and heavy industrial hand protection. Ansell continues to invest in emerging PPE technologies, including enhanced barrier materials, digital customer engagement platforms, and environmentally responsible product lines aligned with global sustainability standards.

Geographic Footprint

Ansell Limited is headquartered in Australia, with corporate offices and operational leadership based in Melbourne. The company maintains a significant presence across North America, Europe, Asia-Pacific, and Latin America, reflecting its globally diversified customer base and manufacturing network. Its products are sold in more than 100 countries through direct sales teams and distribution partners.

Manufacturing operations and sourcing are concentrated in Asia, particularly in countries with established medical and industrial glove production capabilities, while research, product development, and commercial operations are distributed across North America and Europe. This geographic diversification supports supply chain resilience and enables Ansell to respond to regional regulatory and customer requirements.

Leadership & Governance

Ansell is led by an executive team with extensive experience in global manufacturing, healthcare supplies, and industrial safety markets. The leadership emphasizes disciplined capital allocation, customer-centric innovation, and operational excellence, with a strategic vision focused on sustainable growth and long-term shareholder value.

Key executives include:

• Neil Salmon – Chief Executive Officer
• Craig Schubert – Chief Financial Officer
• Michael Szymanski – President, Healthcare Global Business Unit
• Scott Sommerdorf – President, Industrial Global Business Unit
• Mark Brager – President, Life Sciences Global Business Unit

The company operates under a governance framework consistent with publicly listed multinational standards, with oversight from an independent board and alignment with regulatory requirements in its primary listing jurisdiction.